You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Secondary Emission Detector Modules for High Energy Physics Experiments
SBC: NVIZIX LLC Topic: C5637aWe propose simulating and constructing a prototype and demonstration brassboard of a Secondary Emission Sensor Module (SESM) for ionizing radiation, as a proof of principle and guide to Phase II and beyond. The simulation and design studies will guide module construction and point to future uses. The module is anticipated to have ~30 stages of sheet dynode with an areal size ~15x15 cm. It will be ...
SBIR Phase I 2023 Department of Energy -
Multifunctional Ceramic Antifouling, Erosion- and Corrosion-resistant Coating for Hydropower Applications
SBC: NANOIONIX, LLC Topic: C5614bHydroelectric power is the world’s largest source of renewable energy. These massive systems are designed for a 50+ year service life, but this can be shortened substantially by poor water quality and the presence of flowing debris, sediment, minerals, and micro- and macro-organisms. Biofouling (especially from invasive species), corrosion, and erosion (wear) of critical components can limit per ...
SBIR Phase I 2023 Department of Energy -
X-RAY SOURCE FOR DETECTOR CALIBRATION
SBC: omega-p r&d, Inc. Topic: C5602aThe US Defense Nuclear Nonproliferation Research and Development agency has an objective to reduce reliance on high-activity commercial and industrial radioactive sources used in calibration systems. One approach to achieve this goal is by use of novel electron accelerators to produce x-rays that can reach the needed gamma-ray dose rate, repeatability, and stability for calibration, while reducing ...
SBIR Phase I 2023 Department of Energy -
Internal Surface Finishing of Additively Manufactured RF Components for Fusion Reactor Applications
SBC: REM CHEMICALS INC Topic: C5629aStatement of the Problem: In a reactor environment, plasma material interaction (PMI) issues associated with radio frequency (RF) coupling structures are similar to those for the first wall and have been identified as a potential problem. A primary challenge is to obtain high power, breakdown resistant density couplers with low loss compatible with fusion plasmas. Advanced manufacturing techniques ...
SBIR Phase I 2023 Department of Energy -
SBIR Phase I: Antibody Therapy that Targets Neoantigens in Acute Myeloid Leukemia via the Antibody Dependent Cell-mediated Cytotoxicity Mechanism of Natural Killer Cells
SBC: ENABLE LIFE SCIENCES LLC Topic: PTThe broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project focuses on the unique combination of cancer-specific antibodies and adoptive Natural Killer (NK) immune cells needed to offer personalizable cancer therapies.This innovation represents a platform technology that can spawn multiple innovative cancer treatments, which could positively impact lif ...
SBIR Phase I 2023 National Science Foundation -
SBIR Phase I: Software-Defined Networking and Resource Virtualization in Low Earth Orbit (LEO) Satellite Constellations
SBC: UNINET LLC Topic: SPThe broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the extension of state-of-the-art terrestrial 5G technologies to non-terrestrial satellite networks. Non-terrestrial networks (NTNs) are the ideal hosts for many commercial applications involving monitoring, reconnaissance, and remote sensing such as agricultural planting, remote factory op ...
SBIR Phase I 2023 National Science Foundation -
Surveillance and prediction of Swine Influenza A Virus hemagglutinin gene sequences for the rapid development of saRNA-nanoparticle vaccines
SBC: GENVAX TECHNOLOGIES INC Topic: 83Project Summary/AbstractSwine influenza A Virus (IAV) is a highly contagious respiratory virus that is endemic in pigsworldwide. Swine IAV infections represent an enormous economic loss to producers and canresult in acute respiratory disease and severe pathology when acting in concert with otherpathogens. Zoonotic transmissions between pigs and humans are a threat to both human healthand animal pr ...
SBIR Phase I 2023 Department of Agriculture -
Therapeutic Agents Targeting Cryptococcal Infections
SBC: Quercus Molecular Design, LLC Topic: NIAIDCryptococcus species are a clinically important group of opportunistic fungal pathogens that can cause life threatening disease, particularly in the immunocompromised patient population. Historically, this has involved patients with advanced HIV, but is becoming more prevalent in other immunovulnerable populations. The primary pathogens, C. neoformans and C. gattii, are ubiquitous in the environme ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Leptospirosis Vaccine Development
SBC: Luna Bioscience, Inc. Topic: NIAIDSummary/abstract. Leptospirosis is a globally important neglected disease caused by pathogenic Leptospira. It is estimated to cause more than 1 million global cases annually with a 5-20% case-fatality rate, significant morbidity, and important public health consequences. Currently there is no safe and effective vaccine to prevent human leptospirosis. LeptoX, Inc. proposes to develop the first huma ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Novel Treatment for Alcohol-associated Liver Disease
SBC: MITOTHERAPEUTIX, LLC Topic: 350Abstract The Specific Aim of this Phase I TTR proposal is to test the feasibility of our siRNA drug to ameliorate the pathology and progression of alcohol-associated liver disease (ALD). Alcohol consumption remains a leading cause of hepatic pathology worldwide and is one of the greatest sources of preventable morbidity and mortality. In the U.S., alcohol abuse impacts over 10 million individuals ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health